Table 2.
Clinical data of spinal TB group and control group.
| Experimental n = 36 |
Control n = 25 |
|
|---|---|---|
| Age | 56.20 ± 5.80 | 44.20.±11.50 |
| Gender | ||
| Male | 17 (47%) | 12 (48%) |
| Female | 19 (53%) | 13 (52%) |
| Ethnicity | ||
| Han | 8 (22%) | 7 (28%) |
| Minority | 28 (78%) | 18 (72%) |
| Occupation | ||
| Labor-type | 10 (28%) | 6 (24%) |
| Nonlabor type | 17 (47%) | 12 (48%) |
| Freelance | 9 (25%) | 7 (28%) |
| Risk factor | ||
| History of TB | 4 (11%) | 0 |
| HIV | 0 | 0 |
| Main symptoms | ||
| Numbness of both lower limbs | 10 (28%) | 0 |
| Neuropathic pain | 35 (97%) | 0 |
| Systemic symptoms | 11 (31%) | 0 |
| X-ray | ||
| Column destruction | 16 (44%) | 0 |
| Paravertebral tissue shadow | 14 (39%) | 0 |
| Bone chelation and hardening | 1 (2%) | 0 |
| Osteosis | 1 (2%) | 0 |
| Biochemical analysis | ||
| Increased T-SPORT | 16 (44.4%) | 0 |
| Increased CRP | 22 (61%) | 0 |
| Increased leukocyte | 2 (6%) | 1 (4%) |
| Increased M | 25 (69.4%) | 1 (4%) |
Note: TB: tuberculosis; HIV: Human Immunodeficiency Virus; CRP: C-reaction protein; T-SPOT.TB: T cell spot test tuberculosis; M (Monocytes).